Related Experiment Video

Updated: Mar 25, 2026

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
11:27

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

Published on: April 7, 2023

7.8K

[Pediatric emergency medicine]

Kohei Osada, Yoshio Sakurai, Masanori Tamura

    Nihon Rinsho. Japanese Journal of Clinical Medicine
    |February 27, 2016
    PubMed

    Insights

    Pediatric advanced life support (PALS) provides a systematic approach to emergency care for children. Point of care ultrasound (POCU) enhances PALS by offering crucial adjunctive diagnostic information.

    Area of Science:

    • Emergency Medicine
    • Pediatric Critical Care

    Context:

    • Pediatric advanced life support (PALS) is the established global standard for emergency care in children.
    • International Consensus on Cardiopulmonary Resuscitation (ILCOR) guidelines are revised every five years by international experts.
    • PALS utilizes a systematic evaluation of respiratory and circulatory status for diagnosis and treatment.

    Purpose:

    • To outline the core concepts of Pediatric Advanced Life Support (PALS).
    • To introduce the growing role and application of Point of Care Ultrasound (POCU) in emergency medicine.
    • To explore how POCU can serve as an adjunctive tool to physical examination in PALS.

    Summary:

    • PALS relies on systematic patient assessment, focusing on respiratory and circulatory status.
    • Physical examination, while crucial, has limitations in pediatric emergency scenarios.
    • Point of Care Ultrasound (POCU) is increasingly adopted in critical care, offering objective data to complement clinical assessment.

    Impact:

    • POCU can potentially improve diagnostic accuracy and treatment decisions in pediatric emergencies.
    • Integrating POCU into PALS protocols may enhance the effectiveness of emergency care for critically ill children.
    • This review highlights the synergistic potential of combining established PALS principles with advanced POCU techniques.

    More Related Videos

    Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model04:55

    Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model

    Published on: May 26, 2023

    1.5K
    Whole-body PET/MRI of Pediatric Patients: The Details That Matter10:02

    Whole-body PET/MRI of Pediatric Patients: The Details That Matter

    Published on: December 19, 2017

    15.6K

    Related Concept Videos

    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    369
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
    327
    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
    458
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    693
    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    726
    Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

    Cardiopulmonary Resuscitation IV: Pharmacological Management

    Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
    1.3K